期刊文献+

RECK、MMP-2在骨肉瘤中的表达及其临床意义 被引量:6

Expression and clinical significance of RECK and MMP-2 in osteosarcoma
下载PDF
导出
摘要 目的探讨RECK、MMP-2与骨肉瘤的侵袭转移以及预后的关系。方法利用免疫组化技术检测2001年至2004年我院49例骨肉瘤患者组织标本中RECK、MMP-2的表达情况,同时结合患者的相关临床病理特点,进而分析其表达的临床意义。结果49例骨肉瘤患者组织中RECK与MMP-2表达相关(r=-0.603,P<0.05)。单因素分析提示年龄、性别、肿瘤部位、组织亚型与RECK、MMP-2表达无明显相关性(P>0.05),而与肿瘤转移及复发状况相关(P<0.05)。49例骨肉瘤患者5年生存期与RECK、MMP-2表达相关(P=0.003,0.028)。结论RECK、MMP-2与骨肉瘤转移、复发及预后有关,可作为预测骨肉瘤复发、转移及预后的重要参考指标。 Objective To explore the correlation between expression of RECK,MMP-2 and tumor invasion,metastasis and prognosis in osteosarcoma(OS).Methods Immunohistochemisty was employed to determine the expression of RECK,MMP-2 in cancerous tissues of 49 cases with OS.Then combining with the features of pathology and prognostic indicators,we analyzed the relationship between the expressions of RECK,MMP-2 and tumor invasion,metastasis and prognosis in osteosarcoma.Results There was a significant correlation between the expressions of RECK and MMP-2(r=-0.603,P〈0.05).Univariate analysis showed a significant correlation between the expression of RECK,MMP-2 and recurrence,metastasis and prognosis(P〈0.05),and no correlation between the expression of RECK,MMP-2 and age,gender,tumor location and subtype(P〉0.05).Conclusion There are significant correlations among the expression of RECK,MMP-2 and recurrence,metastasis and prognosis.The increasing expression of RECK and decreasing expression of MMP-2 are useful to predict metastasis and prognosis of osteosarcome.
出处 《临床肿瘤学杂志》 CAS 2010年第3期222-225,共4页 Chinese Clinical Oncology
基金 全军医学科研"十五"计划杰出人才基金资助项目(04J005)
关键词 RECK MMP-2 骨肉瘤 预后 RECK MMP-2 Osteosarcome Prognosis
  • 相关文献

参考文献11

  • 1Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk : an analysis of 1,702 patients treated on neo-adjuvant cooperative osteosarcoma study group protocols[J]. J Clin Oncol, 20(3) :776-790.
  • 2Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK[ J]. Proc Natl Acad Sci USA, 1998,95 (22) : 13221 - 13226.
  • 3Takagi S, Simizu S, Osada H. RECK negatively regulates matrix metalloproteinase-9 transcription [ J 1, Cancer Res, 2009, 69 (4) :1502 - 1508.
  • 4Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis[J]. Cell,2001,107(6) :789-800.
  • 5Meng N, Li Y, Zhang H, et al. RECK, a novel matrix metalloproteinase regulator[J]. Histol Histopathol, 2008,23(8) :1003 - 1010.
  • 6Kazumasa T, Shinya I, Yozo K, et al. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer[ J]. Eur J Cancer, 2004, 40(10) :1617 - 1623.
  • 7Taku T, Michiyoshi H, Mitsuo N, et al. The membrane-anchored matrix metalloproteinase regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer[ J]. Clin Cancer Res, 2004, 10( 8 ) :5572 - 5579.
  • 8Figueira RC, Gomes LR, Neto JS, et al. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential [ J ]. BMC Cancer, 2009, 14(9) :20.
  • 9Clark JC,Tomas DM, Choong PF, et al. RECK-a newly discovered inhibitor of metastasis with prognostic significance in muhiple forms of cancer [ J ]. Cancer Metastasis Rev, 2007,26 ( 3-4 ) : 675 - 683.
  • 10Toshihiko M, Ryuichiro D, Takatomo K, et al. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis [ J ]. Clin Cancer Res, 2003, 9 ( 5 ) : 1779 - 1784.

二级参考文献16

共引文献13

同被引文献86

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部